Universe Pharmaceuticals INC 20-F for FY2024
Universe Pharmaceuticals INC (UPC)
20-F
2025-04-29
For: 2024-09-30
View Original
Added on
April 09, 2026
About this 20-F
Universe Pharmaceuticals INC filed this 20-F on April 29, 2025, covering the fiscal year ended September 30, 2024 (FY2024).
Headline figures
Fiscal year ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $23.02M
- down 28.7% from $32.31M a year earlier
- Net loss
- $8.73M
- compared with a net loss of $6.58M a year earlier
- Diluted EPS
- -$626.96
- compared with -$1,089.21 a year earlier